Aug 2026· International Journal of Pharmaceutics: X· Vol 12, pp. 100644· 0 citations· 76 references
Medicine
TL;DR
A dual-carrier hybrid delivery platform is developed to overcome burst release kinetics and achieve sustained local therapeutic levels by integrating microfluidically synthetized nanoparticles with electrospun nanofibrous matrices to mitigate antibiotic resistance while promoting wound healing.
Abstract
Wound infections affect 2% of the global population, causing chronic wounds and healthcare burdens as conventional antibiotics increasingly fail against biofilms. Consequently, attention is shifting toward advanced dressings that simultaneously prevent infection and support tissue regeneration. Among these, fibrous drug delivery systems have emerged as promising platforms for localized and controlled therapeutic delivery. Beyond platform geometry, physicochemical properties of the polymers are paramount in establishing biocompatibility, tunable degradation kinetics, and adequate mechanical integrity. PLGA and PLA/PCL-based nanofibrous platforms exhibit these favorable characteristics, even though they are still limited by issues such as limited control over release kinetics and potential instability of bioactive agents during fabrication. To address the limitations, hybrid platforms combining electrospun nanofibers with drug-loaded nanoparticles have been developed to provide structural integrity and secondary drug reservoirs for sustained release. Here, we developed a dual-carrier hybrid delivery platform to overcome burst release kinetics and achieve sustained local therapeutic levels by integrating microfluidically synthetized nanoparticles with electrospun nanofibrous matrices. To systematically elucidate the role of scaffold structure on the in-vitro performances, two delivery strategies were investigated: (i) direct entrapment of therapeutics within electrospun PLGA and PLA/PCL fibers, and (ii) surface coating of electrospun mats with PLGA nanoparticles. This study uses these approaches to encapsulate a hydrophobic agent, curcumin (CURC), a natural antimicrobial agent with limited solubility, and hydrophilic peptide, bovine lactoferricin (bLFC), which requires protection from enzymatic degradation. The use of these naturally derived compounds offers a promising non-antibiotic strategy to mitigate antibiotic resistance while promoting wound healing.
Recent advances in hydrogel-based approaches are summarized, including antibiotic-loaded hydrogels, systems incorporating anti-biofilm enzymes, bacteriophage-loaded formulations, and nanoparticle-enhanced platforms, aiming to enhance biofilm eradication and improve treatment outcomes in patients with PJI.
Karolina Kraus, Paweł Mikziński, Bindu Subhadra et al.· Microorganisms· 1 citation
This review systematically summarizes the major antibacterial mechanisms of hydrogels, including cationic contact-killing, chemical antibacterial activity mediated by metal ions and reactive halogen species, nanozyme-catalyzed reactions and bidirectional regulation of reactive oxygen species, as well as photothermal sy...
Peng Liu, Lin Chen, Jin-Jun Tian et al.· Gels· 0 citations
A novel integration of capsaicin-mediated silver nanoparticles within a chitosan–alginate biopolymeric matrix is introduced, providing a multifunctional strategy that enhances both antimicrobial efficacy and wound regeneration compared to conventional systems.
M. Khaire, P. Bigoniya, Rohini C. Kolhe· Journal of Pharmaceutical In...· 0 citations
Antibacterial hydrogel microneedles (HMNs) have emerged as promising wound-care platforms by integrating the therapeutic versatility of hydrogels with the minimally invasive tissue penetration of microneedles. This review summarizes recent advances in antibacterial HMNs, focusing on the interplay among material composi...
Ji-Hong Li, Wei Wei, Ying Li et al.· Advanced Healthcare Material...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.